The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
MSD Animal Health has launched Expertis Udder Health, a farm management tool for veterinary surgeons to better enable them to monitor and improve udder health in dairy cattle.
Expertis was presented to vets at the International Conference on Udder Health and Communication which took place in Utrecht this week.
Expertis Udder Health consists of a software programme together with educational and communication tools to help veterinary surgeons and farmers find the causes of mastitis more easily.
The Expertis Udder Health program consists of four steps: 1. A farm intake questionnaire about setting goals puts the farmer in a central position, and allows for careful listening in order to align with his/her objectives. 2. The data is analyzed, leading to the identification of the right focus points that are needed to identify areas for improvement. 3. These focus points are presented as fact sheets, i.e. a check list of risk factors for mastitis within the focus point. 4. The information is synthesized into an automatic summary of the actual situation, the udder health objectives and an open space to fill in the tailor-made advice to the farmer for improvement of the udder health status on his farm.
Jantijn Swinkels, DVM, Global Technical Director Pharmaceuticals within the Ruminants Business Unit at Merck Animal Health said: "The structured approach offered by Expertis Udder Health takes into account that mastitis is a multifactorial disease and covers all aspects that influence udder health. To save time, the analysis ensures that the focus is on the most important issues, which can differ greatly from farm to farm. The existing services provided within this tool can be used to optimize udder health on the farm".
Rinse Jan Boersma, MSc, Global Director Dairy Cattle at Merck Animal Health added: "We have developed Expertis to support veterinarians and farmers by improving our service level as well as to contribute to good veterinary practices by implementing preventive measures and prudent use of antibiotics."
MSD says that as a consequence of the reduced milk production, discarded milk, veterinary and treatment costs and extra labor costs, mastitis is considered the most important cause of economic loss for dairy operations. Recent data from Sweden indicates an average economic loss of €278 per case of clinical mastitis and of €60 per case of sub-clinical mastitis.*
The Expertis Udder Health program is being rolled out country to country, and will be distributed to veterinary surgeons via local MSD Animal Health representatives.
Reference
* Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 2010;4:1758-70
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
Elanco (maker of Comfortis) has released the results of a survey of 1006 dog owners which showed that nearly half are not aware that turning on their central heating can cause pupal fleas to hatch and go in search of a host to feed on.
50% of those questioned said their dog has had fleas at some point. Of those, 79% said their dog gets infested at least once a year. 20% said they did not believe fleas would be found in the carpet, dog bedding and soft furnishings, and over a third didn't treat their carpets or soft furnishings when their home became infested.
Elanco says it has extended its range of practice support materials available to help educate dog owners about flea infestation and the benefits of veterinary prescribed flea treatments. They include client leaflets, waiting room posters and assistance with bespoke direct mail client communications.
For further information, contact your local Elanco Animal Health key account manager.
Woodley Equipment Company Ltd has been appointed as the UK and European master veterinary distributor for the Mythic 18 Vet haematology analyser manufactured by Orphee-Medical, Switzerland.
The Mythic 18 Vet is a fully automated, 18 parameter haematology analyser dedicated for veterinary applications. Woodley says it delivers the ultimate technology in haematology, requires little maintenance and benefits from low reagent consumption. It's quick and easy to use with touch screen technology and can produce accurate results in just 60 seconds for over 10 different species using a small sample volume.
For more information, visit: www.woodleyequipment.com, email: sales@woodleyequipment.com or call: +44(0)1204 669033
Animalcare Ltd has launched Tilmodil (tilmicosin 300mg/ml solution for injection), a semi-synthetic macrolide antibiotic licensed for pneumonia in cattle and sheep, foul in the foot in cattle, and footrot and mastitis in sheep.
According to the company, Tilmicosin is fast-acting1, long-acting2 and highly effective against the major Gram-ve bovine respiratory pathogens.2,3 In addition, the company says tissue penetration is excellent.1 In calves a single SC injection at 10mg/kg bw results in lung concentrations exceeding the MIC90 of Mannheimia haemolytica for 72 hours.2
Animalcare says that pooled data from greater than 6000 cattle has confirmed the effectiveness of tilmicosin in the treatment of bovine respiratory disease (BRD) in well-controlled, randomised field studies. Tilmodil treatment has been proven equally effective compared to antibiotics, such as florfenicol, marbofloxacin and danofloxacin.
A recent report by the Farm Animal Welfare Council estimates that three million of the national sheep flock are lame at any one time. It is estimated that footrot is responsible for greater than 90% of lameness and is present in 97% of flocks. Tilmicosin has good activity against the key Gram-ve pathogens2 and has been successfully used in the treatment of footrot.4
Tilmodil has been developed for animal use only and is administered by veterinary surgeons only. Dosage is 1ml per 30kg bw for respiratory disease and mastitis in sheep and 0.5ml per 30kg bw for interdigital necrobacillosis (foul in the foot/footrot/bovine pododermatitis).
Tilmodil is administered as a single, low volume subcutaneous (SC) injection dose and presented in 50ml multi-dose vials.
References
1. Apley M., Antimicrobial therapy of Bovine Respiratory Disease.Veterinary Clinics of North America.Food Animal Practice (1997) 13,3:159-5622. Tilmodil SPC3. Giguere S et al .,Antimicrobial therapy in Veterinary Medicine.4th edition 2006.Chp.12,2014. Winter A., Lameness in sheep. 2. Treatment and control. In Practice (2004),3, 130-139.
Fiona Knight, a Customer Care Manager from the Woodcroft Veterinary Group in Cheshire, has won the 'Petplan Insurance Advisor Award 2011'.
The award, announced at the British Veterinary Nursing Congress in Kettering, recognises the hard work and dedication that Petplan Insurance Advisors do to highlight the importance of insurance to pet owners.
Fiona said: "It was such a shock to actually win the award, I'm very pleased!. All the finalists, including me, have worked incredibly hard to carry on promoting something we feel so strongly about. It's not something we can do on our own which is why I am so grateful for the dedication and support from my team at the practice.
"The Petplan PIA is such a great scheme as it helps increase the awareness of pet insurance, and really helps owners have financial security and their pets get the best treatment should anything happen."
The finalists were judged by Petplan Business Developers Lisa Allen and Spencer Jones.
Spencer said: "All three finalists have worked extremely hard to educate pet owners about pet insurance so that they are able to give their customers informed and up-to-date advice, however Fiona's commitment and dedication really stood out and she is a very deserving winner."
As part of her award Fiona receives a 16GB Ipad2 with WiFi, worth £399. The other finalists were Harriet Goulden, veterinary nurse at the Feldon Veterinary Centre in Leicestershire, and Alison Sawyer, receptionist at Medivet in Watford.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
Following the announcement from the Dogs Trust that the number of stray and abandoned dogs has reached an 11 year high, Pedigree has launched it's fourth annual Adoption Drive.
The campaign, which seeks to raise awareness and funds for the thousands of strayed and abandoned dogs in the UK, comes at a time when recent statistics put the number of dogs being picked up by local authorities in the last year at 126,176 - the worst in over a decade.
Since its launch, The Pedigree Adoption Drive has raised over £1million for rescue centres up and down the country who are working tirelessly to find new and loving homes for abandoned dogs. Last year alone, grants of almost a quarter of a million pounds were distributed to 34 rescue homes and went towards funding the vital refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and wildlife vet Steve Leonard, who is supporting this year's campaign, said: "Rescue centres across the country are at capacity due to the overwhelming number of stray and abandoned dogs in Britain - a number which is sadly still on the rise. We need to work together to make people aware of this issue and educate them about both the benefits and commitment involved in owning a dog. The funds and support generated by this campaign, help to give abandoned dogs everywhere a second chance at the loving homes they deserve."
During the campaign, Pedigree is sponsoring Pete Wedderburn's blog on www.vetsurgeon.org
Boehringer Ingelheim Vetmedica and the Feline Advisory Bureau (FAB) have launched Spot The Signs, a campaign designed to help owners spot the signs of painful, age-related conditions in cats, such as arthritis.
According to the company, which makes Metacam, 46% of cats are now classed as 'mature and older', and 87% of vets have treated cats aged 22 or more. Yet a survey of 3000 cat owners found that 75% would not recognise the signs of chronic pain in their cat. And despite 50% of owners believing that cats suffer pain the same way as humans, 78% of cats had never been taken to the vet for an old age check up.
99% of 77 veterinary surgeons surveyed agreed that chronic pain often goes unnoticed and that signs of pain can be confused with cats simply getting old. When shown a list of common signs of long term pain in cats, 65% of owners recognised at least one of these signs in their own cat.
Claire Bessant, leading feline author and CEO of FAB, said: "In a recent study, 65% of cats aged 12 and above showed evidence of arthritis when X-rayed. The survey also showed that a large proportion of cats do show signs that may be caused by chronic pain, including becoming withdrawn, reduced grooming and reduced activity, but these were not attributed to pain by the owners. Arthritis has only just been recognised by the veterinary profession as a major problem in cats and so it is not surprising that 80% of cat owners do not realise that their cats can develop this painful condition."
Most owners understand that arthritis can cause significant pain and discomfort, and 93% said they would feel guilty if their cat was in pain and they hadn't realised. 65% of Brits see their cat as member of the family, with 20% saying their cat is like a child to them.
The Spot the Signs campaign is being 'fronted' by Jess the Cat, Postman Pat's sidekick, with expert support from a panel of cat medicine and behaviour specialists including leading feline author Claire Bessant and VetSurgeon.org / VetNurse.co.uk blogger, Pete Wedderburn MRCVS. The campaign includes support materials for veterinary practices and a facebook page.
Claire Fowler, Boehringer Ingelheim, said: "Despite a steady increase in the number of cases of arthritis and chronic pain in cats being diagnosed, our research shows awareness amongst cat owners of how to look for pain in their cats remains surprisingly low, despite 86% saying they would want their vet to let them know if their cat might be in pain. For many owners, spotting the signs of pain in their cat can be difficult, so we have set out to educate cat owners about what to look for and to encourage them to consult their vet or vet nurse if they are concerned."
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Pet owners who believe in preventative healthcare have maintained or increased the money they spend on their pets this year, and 84% visited their vet at least once in 2010, up from 78% in 2007, according to a survey commissioned by the National Office of Animal Health.
According to the survey of 1000 owners carried out by Noesis, 44% of 'preventers' increased their spending on their pets in the last year with only a very small number (5%) decreasing it. There has also been a significant increase in the number of dogs insured by this group since 2007, which now stands at 55% compared to 41% in 2007.
The research covered both 'preventer' and 'non-preventer pet owners and sought to understand: awareness of preventative medicine in cats and dogs; how the decision is made as to what areas of preventative medicine are important and which to adopt; what types of preventative medicine are carried out and the reasons and frequency of this behaviour as well as the sources of information.
In addition to visiting their vet more frequently and spending more on their pets, preventers also visited a pet shop significantly more often than non-preventers with nearly two thirds (61%) of preventers visiting at least once a month compared to 36% of non-preventers, a figure that has decreased from 43% in 2007.
Looking at specific preventative treatments, attitudes to vaccination had not changed between the 2007 and 2010 surveys, with preventers believing that being a responsible pet owner means regularly vaccinating your pet, while non-preventers did not believe vaccination was relevant to their situation. This points to a clear need to educate non-preventers to break habits that have sometimes been handed down from generation to generation.
Most owners from both groups had used a flea treatment on their pets in the past two years although 68% of preventers were much more proactive in their usage of flea products compared to only 40% of non-preventers. Cats (80%) are more likely to have been treated than dogs (69%) among both groups of owners although flea treatment of cats has significantly decreased among non-preventers since 2007.
Use of wormers was also in decline. Although 86% of preventers worm proactively as part of a healthcare routine for their pet, this figure has decreased from 96% in 2007. Non preventers chose not to worm because they did not see the need, citing reasons such as their pet being fit and well or not going outdoors. Likewise, although preventers are more likely than non-preventers to be aware of the zoonotic implications of pet parasites, this awareness had decreased since 2007 pointing to the need for more work to be done on this aspect of pet health. On a more upbeat note, those that were worming proactively wormed their pets more frequently with 50% worming at least every three months in 2010 which was significantly more than compared to 41% in 2007.
When asked where they obtained general healthcare advice, the vet was the most frequently cited source of information with 84% of preventers and 58% of non-preventers referencing their vet. The internet is an increasingly important information channel for non-preventers with almost a third (31%) citing it as their source for pet healthcare advice, an increase from 25% in 2007.
There was huge interest from both groups (87% of preventers and 79% of non-preventers) in using a dedicated website such as NOAH's http://www.pethealthinfo.org.uk/ which 10% of the pet owners surveyed had heard of. It was welcomed for providing easy access, immediate, independent advice and being written by veterinary experts.
Commenting on the research, Phil Sketchley, chief executive of NOAH said: "We commissioned the original piece of research in 2007 to understand the differences between both groups of pet owners and understand where they sourced their information in order to influence the pet healthcare habits of the non-preventers in particular. The importance of the internet as a source of information proved that our strategy to launch http://www.pethealthinfo.org.uk/ was on target and the latest survey shows that this channel is increasingly important, particularly among non-preventers.
"The 2011 survey also reveals some positive insights into the preventative healthcare habits of those pet owners that we termed preventers. This group are more likely to insure their pet (45% vs 12%), go to the vet at least once a year (84% vs 30%) and visit a pet shop at least on a monthly basis (61% vs 36%). And, as a final piece of good news, this group have increased their total spend on their pets in the last year and very few members of either group had decreased their spend.
"Whilst all pet owners consider themselves responsible clearly some do not see regular preventative healthcare as part of that responsibility. So there remains a clear need to educate pet owners, particularly the non-preventers, to change some of the patterns of behaviour and complacency regarding their pet's health that have become entrenched and seem to have been influenced by friends and family."
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Vetoquinol is launching Forcyl, an injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, in November.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, which the company says will ensure a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Vetoquinol says that other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours).
For further information on implementing the SISAAB concept in your practice, please contact one of Vetoquinol's large animal team on 01280 814500.
Hill's has launched 'Lose 60 Tonnes in 6 months', a campaign to help clients get their pet to a healthy weight.
Sixty tonnes is equivalent to the weight of twelve elephants, which is a huge target. Hill's says that if every practice makes a small contribution, it can be achieved.
Hill's support includes a public relations pack which the company says contains everything veterinary surgeons and nurses need to help raise awareness and encourage pet owners to bring their pets in for a weight assessment. The pack includes proforma press releases and guidance on how to cultivate a mutually beneficial relationship with local media. There is also a 'Lose 60 tonnes in 6 months' point of sale kit that includes a poster, stickers and a noticeboard kit for clinics, to drive awareness while clients wait for consults.
As part of the campaign, Hill's is also hosting a series of nurse webinars on weight management and offering additional support material such as consult room posters, weight clinic packs and pet tape measures, an item often requested by nurses. There are also promotional offers available through Hill's Territory Managers, subject to stock availability.
Hill's Customer Marketing Manager, Sara Locke MRCVS said: "We feel it is important to support practices at the grass-roots level and to develop a campaign that will have real meaning within the local community. I hope practices will get behind it, engage with pet owners and as a result, gain new clients. They are also helping thousands of pets live longer and happier lives."
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
The BSAVA has launched a new app for iPhone / Android users, the Guide to Procedures in Small Animal Practice.
The guide, which is aimed at vets and students, covers more than 70 of the diagnostic and therapeutic procedures commonly performed in small animal veterinary practice.
The Association says it always planned to extend the number of digital member benefits, but has been spurred on by feedback about its Formulary app, like this comment from 'talland' on the iTunes store: "Absolutely fantastic App - in some ways even easier to use than the book itself. Well done BSAVA. It'd be great if the Guide to Procedures in Small Animal Practice could be an App too".
The BSAVA says the key features of the new app are:
Once installed on your phone you will need to launch the Application by entering a unique activation code which can be obtained from the App Activation Code page (member login required).
The British Veterinary Association has criticised the conclusions drawn by the Gloucestershire Wildlife Trust in its report on badger vaccine deployment.
The report considers the effectiveness of the Trust's programme of deploying the injectable BadgerBCG vaccine in seven nature reserves covering only 170 hectares (1.7 sq km) during the summer.
It concludes that the badger vaccine is a viable alternative to culling in the battle against bovine TB, but according to the BVA, does not give evidence to support this claim.
Carl Padgett, President of the BVA, said: "We welcome the initiative by the Gloucestershire Wildlife Trust to investigate the deployment of the badger vaccine but this work must not be confused with an investigation into the effectiveness of the badger vaccine in reducing or eradicating bovine TB.
"To conclude from this report that the badger vaccine is a viable alternative to culling in eradicating TB is unrealistic at best and spin at worst.
"The fact remains that the vaccine has no protective effect on infected badgers and we know that at least 30-40% of badgers within an area will be infected. Many young badgers will be infected before they can be trapped and injected.
"In terms of the practicalities of deployment this report provides interesting information but we will learn much more as a result of Defra's Badger Vaccine Deployment Project which is looking at a much larger area of 100 sq km.
"Vaccination of badgers certainly has a role to play in an effective TB eradication programme but it is only one tool in the toolbox."
Bayer Animal Health is to hold a free webinar for companion animal veterinary surgeons about its new fluoroquinolone for cats and dogs, Veraflox.
The one-hour webinar begins with a talk on mutant prevention concentration (MPC) from Dr Joe Blondeau, head of clinical microbiology at the Royal University Hospital & the Saskatoon Health Region, in Canada. He's followed by Dr E Bensignor, President of the European College of Veterinary Dermatology, who will present the findings of clinical studies. The final presentation by Dr Joy Olsen, global veterinary services manager for Bayer Animal Health, reviews the features and characteristics of Veraflox (pradofloxacin) and its use in cats and dogs.
The webinar can be watched live on Tuesday 25 October at 7:30pm, when you'll have the opportunity to put questions to the speakers. Alternatively, a recording of the event can be viewed at any point afterwards.
To register, visit http://nl.webcast3.animalhealth.be/nl/english-subscription#ht=944, to receive a login name and password.
For further information on Veraflox, contact your Bayer representative or call 01635 563000.
Woodley Equipment Company Ltd has announced the launch of InSight rapid diagnostic test kits. The test range includes FeLV, FIV, FeLV-FIV Combi, Giardia, Canine Heartworm, Canine Parvovirus and with more tests in development.
The test kits are available to veterinary practices across the UK and to Woodley's global veterinary diagnostic distributors. Each test is based on a sandwich lateral flow immunochromatographic assay and contains 10 cassettes per box. The company says that the diagnostic kits are simple and easy to use and will provide point of care testing direct to the veterinary practice. The kits are stored at room temperature (2⁰C - 30⁰C).
The range of InSight Rapid Diagnostic Tests includes:
To place an order, email sales@woodleyequipment.com, fax 01204 669034, or telephone 01204 669033.
For more information, visit: http://www.woodleyequipment.com/.
The RCVS Veterinary Nurses Council has celebrated the 50th anniversary of veterinary nursing at the House of Commons with a call for statutory regulation for the profession.
At a Golden Jubilee event hosted by Mr Roger Gale MP, Veterinary Nurses Council Chairman Liz Branscombe drew attention to the fact that there is no legal protection for the title 'veterinary nurse', despite qualified nurses playing "a unique role in the practice team".
This effectively means that anyone could work in a veterinary practice as a nurse, without taking the three- or four-year training required for Listed or Registered Veterinary Nurses.
Liz said: "We believe that the nation's animals and their owners deserve better than this. And it's not just a question of animal welfare: public health is at risk from the incorrect use of medicines - for example, the well documented development of antimicrobial resistance."
The Veterinary Surgeons Act 1966 was put in place only five years after the introduction of veterinary nurse training and too soon to fully recognise the potential of veterinary nursing as a profession in its own right.
As an interim measure, the RCVS has put in place a non-statutory Register for Veterinary Nurses, to which 86% of eligible nurses have signed up. Registered Veterinary Nurses agree to follow a code of conduct, keep their skills and knowledge up to date and abide by a disciplinary system. However, it is not possible for the College to bar those removed from the Register for serious professional misconduct from working as a veterinary nurse.
The Register also does not address the misuse of the title 'veterinary nurse' by unqualified people.
Liz asked MPs present at the House of Commons reception to sign up to an Early Day Motion tabled by Andrew Rosindell MP, which calls for statutory regulation for the veterinary nursing profession.
Others are urged to sign a petition on the Government's website which has been mounted by the British Veterinary Nursing Association and is supported by the College and the British Veterinary Association: http://epetitions.direct.gov.uk/petitions/18700.
The issues are being considered by the RCVS Veterinary Nurses Legislation Working Party and the group's recommendations will feed into the wider work of the RCVS Legislation Working Party, which will be reporting to the Defra Minister of State in the summer of 2012 with proposals as to how statutory regulation could be provided for a range of veterinary services, including veterinary nursing.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The RCVS Veterinary Nurses Council has decided that the College should cease being an awarding body next year, which means it will no longer offer the vocational Level 3 Diploma in Veterinary Nursing.
The College says it will ensure that the Diploma continues to be available by transferring the intellectual property associated with the qualification, such as the question banks and systems, to another larger awarding body, in a move which is likely to take effect for the beginning of the 2012 academic year.
According to the College, this decision reflects recent changes in the regulatory Conditions of Approval for awarding bodies, which it would have been hard for the College to meet while continuing to offer the Diploma cost-effectively. The changes mainly relate to potential conflicts of interest between the College's primary role, as professional regulator that safeguards standards within the veterinary professions, and its role as an awarding body. The standards-setting role includes the regulation of education and training leading to the veterinary and VN registers, and it was felt that the College could no longer exercise this role effectively if it was also an awarding organisation, as it might be suspected of treating its internal qualifications more favourably, or of obstructing competitors.
Although the College says this has not been a problem in the past, the rules are now more stringent, and the costs of setting up a fully independent awarding body would be prohibitive.
The market for the Diploma is also likely to fragment in the future, with three other awarding bodies expressing an interest in offering a Level 3 Diploma. Any reduction in the number of students taking the RCVS Level 3 Diploma would further push up the costs, potentially making the RCVS Awarding Body unviable. A larger awarding body can take advantage of economies of scale across a range of awards in a way that the RCVS cannot.
Colonel Neil Smith, Chairman of the RCVS Awarding Body Board said: "The RCVS has been offering vocational qualifications since 1998 and the decision to cease being an awarding body has not been taken lightly.
"We have taken this decision in order to focus on our core responsibilities of professional regulation and standard setting. However, we remain committed to maintaining the Diploma, which has been carefully developed by the RCVS and the profession. This move ensures that it will stay in safe hands."
The name of the awarding body to which the qualification will be transferred has not yet been announced because the process is not complete. However, the College says it felt it was important to give those involved with the delivery of training as much notice as possible of the change. More information, and the change-over plan, will be released in due course.
Libby Earle, RCVS Head of Veterinary Nursing said: "Our priority will be effecting a smooth transfer for students, Colleges and training practices, and we are confident that the impact of the change will be minimal. Furthermore, it will be a condition of the transfer that the veterinary profession continues to have a say in the future development of the qualification."
Those students still in the process of completing the old NVQ qualifications, the accreditation of which is due to run out in 2013, will continue to be serviced by the RCVS.
As the professional regulator, the College will continue to issue RCVS certificates and badges to those who have successfully completed a registerable qualification - such as an approved vocational qualification run by another awarding body, or an RCVS-recognised veterinary nursing degree.
The Advanced Diploma in Veterinary Nursing will be unaffected by the change as the qualification is awarded by the College under its Royal Charter powers.
The RCVS has opened a consultation on the future of veterinary specialisation, which includes a proposal that the use of postnominals and titles by veterinary surgeons should be rationalised in order to avoid confusion amongst the public.
The proposals are submitted for comment by the RCVS Specialisation Working Party, which is chaired by former Chief Medical Officer Professor Sir Kenneth Calman.
The Working Party's review was precipitated by a finding that the structure of veterinary specialisation is "confusing and opaque" to both animal owners and the profession (Unlocking Potential - a Report on Veterinary Expertise in Food Animal Production, by Professor Philip Lowe, 2009).
The Working Party has explored the routes to RCVS Recognised Specialist status. It has also looked at the use of 'specialist' more broadly, given the fact that it is not a protected term in the veterinary field, and has considered animal owners' expectations of a 'specialist'.
The Working Party also makes proposals for encouraging more veterinary surgeons to become specialists, given that there are currently only 319 on the RCVS List of Recognised Specialists, out of a UK practising arm of the profession of some 17,400 veterinary surgeons.
The proposals from the Working Party could have far-reaching impact. One suggestion is that all those meeting the criteria for specialist status would also become Fellows of the RCVS (FRCVS) - a status currently only held by those who complete a thesis or exam, or who qualify on the basis of 'meritorious contributions to learning'. There are also proposals that the term 'RCVS Recognised Specialist' be dropped and replaced with the much simpler term 'specialist' or 'veterinary specialist'.
Further proposals include the introduction of a 'middle tier' of veterinary surgeons - potentially to be called 'advanced practitioners' - who would be below full specialist status and subject to periodic revalidation.
There are also recommendations that veterinary surgeons should be obliged to explain referral options to their clients, including the level of expertise of those to whom they are referring cases.
The future of the RCVS subject boards, which currently manage the various Certificate and Diploma examinations, is also considered in the proposals.
The emphasis throughout is on simplification and improvement, according to Professor Sir Kenneth Calman, who said: "New legislation to introduce statutory registration for veterinary specialists would no doubt make things clearer, as it is for doctors and dentists, but, in the meantime, we believe there are a number of actions which the RCVS could take to improve matters."
The consultation paper can be downloaded from www.rcvs.org.uk/consultations, and comments are welcomed from members of the public, veterinary surgeons and veterinary nurses. The closing deadline for comments, which should be sent to RCVS Head of Education, Freda Andrews, on f.andrews@rcvs.org.uk, is Friday 9 December.
Comments received will be considered by the RCVS committees and Council in early 2012.
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
VetUK, an online supplier of pet products and veterinary prescription only medications, has announced that it now processes over £750,000 worth of online transactions per month.
The point of the press release was to highlight that this has been achieved using paypoint.net to handle the tens of thousands of orders that VetUK says it receives each month, and process the payments.
However, it does also highlight the ever growing competition to veterinary practices from online. You might like to check VetUK's POM prices here.